F Fuzkk Atlas of the USA
#84FUZKK atlas leaders 1–100

Guardant Health

California

Molecular diagnostics

Manufacturing profile

Molecular diagnostics

Biopharma hub: California

Selection basis

The company is placed in positions 1–100 as a major participant in the U.S. pharmaceutical, biopharmaceutical, generics or manufacturing/CDMO ecosystem.

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.

Representative manufacturing and QC chain

  1. 1Reagent, calibrator and control preparation
  2. 2Assay, sequencing or analyser workflow
  3. 3Software algorithms and result calculation
  4. 4Analytical performance and stability
  5. 5Risk, software, cybersecurity and data-integrity evidence

Relevant FUZKK packages

United States: national essential medicines QC packageMedical Devices Standards & Lifecycle QC SuiteMedical Device Software SuiteMedical Device Risk Management Suite

Product/API utilities

Companion Diagnostic Report Checker

Lumex — instrumental QC

System Suitability Parameters Checker

LabEx — laboratory QC

Microbial Enumeration (TAMC/TYMC) Quality CheckerSpecified Microorganisms Quality CheckerStability Condition Monitoring Quality CheckerEnvironmental Monitoring Cleanroom Quality Checker

Medical Devices — equipment and software lifecycle

Requirement Traceability CheckerSoftware Safety Class CheckerIntegration Test Coverage CheckerData Integrity Security CheckerCybersecurity Risk Assessment CheckerElectrical Safety Test Summary CheckerEMCTest Coverage CheckerCalibration Status CheckerSupplier Evaluation CheckerProcess Validation CheckerChange Control Impact Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.

Methodology